MedCity News

New Cohere Health Solution Aims to Streamline Clinical Reviews for Payers

Precision Medicine Firm Caris Breaks Bio IPO Drought, Raising $494M for Cancer Analysis Tools

Caris Life Sciences applies AI and machine learning to patient samples to detect cancer and as a companion diagnostic guiding the use of targeted cancer therapies. As a commercial-stage company, Caris’s upsized public markets debut is an outlier amid the continuing IPO freeze for clinical-stage biotechs developing new drugs.

By Frank Vinluan

Startups, Artificial Intelligence Providers,

Why Intermountain Health Is Investing In AI for Clinical Data Abstraction

Intermountain Health is deploying Layer Health’s AI engine for clinical data abstraction across several of its patient registries. The health system’s venture capital arm is also making a strategic investment in the startup.

By Katie Adams

MedCity Influencers

What OpenAI’s o3 Price Drop Means for the Future of AI in Healthcare?

To be clear, this doesn't mean healthcare organizations should adopt LLMs tomorrow. But what’s changed is that the primary obstacle - cost at scale - is no longer the immovable obstacle it once was. For healthcare leaders who have been watching the AI wave from the sidelines, this is the moment to move from curiosity to action.

By Justin Liu

Latest News

MedCity Influencers

The MFN Executive Order: A Global Reset for U.S. Pharma

It's a bold attempt to recalibrate global drug pricing — with U.S. patients at the center. But without clear enforcement, legal grounding, or international cooperation, its future remains very uncertain.

By Glenn Hunzinger

Startups Providers,

Bluebird Kids Health to Expand By Opening New Pediatric Clinics

Just a year after its launch, Bluebird Kids Health is already announcing plans to double its number of pediatric clinics. The startup seeks to improve pediatric care access in underserved areas by building practices in these neighborhoods and accepting all insurance types.

By Katie Adams

Health Tech

Sword Health Raises $40M, Launches Mental Health Solution

Sword Health's $40 million funding round was led by General Catalyst. In total, the company has raised $300 million. The most recent round brings its valuation to $4 billion.

By Marissa Plescia

BioPharma, Startups

Draig Therapeutics Emerges With $140M for Clinical Tests of Novel Neuropsychiatric Drugs

Draig Therapeutics’ lead drug is designed to safely target the AMPA receptor as a way of mediating the interplay between two neurotransmitters whose imbalance is associated with mood disorders. The startup is one of several that have recently raised mega rounds of financing to support programs in the clinic or entering clinical testing.

By Frank Vinluan

MedCity Influencers

How Emerging Hospital Bed Technology Can Help Patients Rest Easier And Recover Faster

Despite their necessity, beds and surfaces do not always receive proportional attention and innovation — even as the risks associated with prolonged bed rest remain a key priority for caregivers.

By Bettyann Bird

MedCity Influencers

AI Governance: Building Trust and Transparency for Healthcare AI

Those who recognize that AI governance is an innovation enabler will be able to align business priorities and AI investments — and make smarter decisions about which models to accelerate, and which to retire — ultimately leaving the enterprises better positioned to achieve ROI on their AI.

By Pete Foley

MedCity Influencers

Taking The Wheel: A Proactive Approach to Improving Longevity

When you equip patients with a deeper understanding of their bodies, they are better prepared to act on medical advice.

By Jason Barker

MedCity Influencers

The Benefits of Establishing a Data-driven Culture in Healthcare

Ultimately, the benefits of establishing a data-driven culture reach far beyond improved analytics. It enables a smarter, faster, and more inclusive decision-making process that leads to better care for patients, reduced provider burnout, and stronger financial resilience

By Peter Calderone

Discover the Hidden Costs of Siloed Systems

Is your provider data holding you back?

By ProviderTrust

BioPharma, Pharma

Gilead Sciences Lands First FDA Approval of a Twice-a-Year HIV PrEP Drug

Gilead Sciences drug lenacapavir, brand name Yeztugo, is now approved for HIV pre-exposure prophylaxis. The twice injectable medication is hoped to improve uptake and adherence to PrEP.

By Frank Vinluan

Health Tech, Payers

Cigna Launches 6 New Digital Tools To Improve Customer Experience

Cigna's new digital tools include an AI-powered virtual assistant, personalized provider matching and cost tracking.

By Marissa Plescia

Hospitals, Health Tech, Artificial Intelligence, Providers

What Will Be Healthcare’s Next Big AI Use Case Following Ambient Scribes?

Over the past couple of years, ambient scribes have earned widespread adoption among health systems. While there's excitement around other categories like AI agents, no other AI use case has achieved ambient scribes’ level of traction, noted Daniel Yang, Kaiser Permanente’s vice president of AI and emerging technologies.

By Katie Adams

Startups

Are You a Startup Seeking to Redefine Healthcare Operations with AI? Apply to Pitch Perfect at INVEST Digital Health

The healthcare startup pitch contest will be the centerpiece of INVEST Digital Health in Dallas on September 18. Apply today!

By Stephanie Baum

MedCity Influencers

Why Doctors Are Becoming the First Stop for Mental Health — and What Comes Next

This is not a burden primary care should bear alone. It’s an opportunity to strengthen the connection between mental health providers and medical professionals and build a care model that reflects how people actually seek help.

By Dan Frogel